Bausch Health Companies | Des Atouts



Assets Changement Date
Amgen USD 89.37B 2.47B 2025-03
ANI Pharmaceuticals USD 1.29B 8.73M 2025-03
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 26.42B 102M 2025-03
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 846.46M 5.9M 2025-03
Danaher USD 79.12B 1.57B 2025-03
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Novo Nordisk 489.16B 91.72B 2025-03
Pacira USD 1.59B 33.15M 2025-03
Perrigo USD 9.76B 112.1M 2025-03
Prestige Brands USD 3.4B 72.72M 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zoetis USD 14.1B 139M 2025-03



Bausch Health Companies Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.